§FMCSR.com
Historical textIn force on Dec. 5, 2017Source: eCFR

§ 40.29 Where is other information on employer responsibilities found in this regulation?

Wording effective November 13, 2017, superseded January 1, 2018.

eCFR as of December 5, 2017 ↗

Link to an amendment published at 82 FR 52244, Nov. 13, 2017.

You can find other information on the responsibilities of employers in the following sections of this part:

§ 40.3 - Definition.

§ 40.35 - Information about DERs that employers must provide collectors.

§ 40.45 - Modifying CCFs, Use of foreign-language CCFs.

§ 40.47 - Use of non-Federal forms for DOT tests or Federal CCFs for non-DOT tests.

§ 40.67 - Requirements for direct observation.

§§ 40.103-40.105 - Blind specimen requirements.

§ 40.173 - Responsibility to ensure test of split specimen.

§ 40.193 - Action in “shy bladder” situations.

§ 40.197 - Actions following report of a dilute specimen.

§ 40.207 - Actions following a report of a cancelled drug test.

§ 40.209 - Actions following and consequences of non-fatal flaws in drug tests.

§ 40.215 - Information about DERs that employers must provide BATs and STTs.

§ 40.225 - Modifying ATFs; use of foreign-language ATFs.

§ 40.227 - Use of non-DOT forms for DOT tests or DOT ATFs for non-DOT tests.

§ 40.235 (c) and (d) - responsibility to follow instructions for ASDs.

§ 40.255 (b) - receipt and storage of alcohol test information.

§ 40.265 (c)-(e) - actions in “shy lung” situations.

§ 40.267 - Cancellation of alcohol tests.

§ 40.271 - Actions in “correctable flaw” situations in alcohol tests.

§ 40.273 - Actions following cancelled tests in alcohol tests.

§ 40.275 - Actions in “non-fatal flaw” situations in alcohol tests.

§§ 40.287-40.289 - Responsibilities concerning SAP services.

§§ 40.295-40.297 - Prohibition on seeking second SAP evaluation or changing SAP recommendation.

§ 40.303 - Responsibilities concerning aftercare recommendations.

§ 40.305 - Responsibilities concerning return-to-duty decision.

§ 40.309 - Responsibilities concerning follow-up tests.

§ 40.321 - General confidentiality requirement.

§ 40.323 - Release of confidential information in litigation.

§ 40.331 - Other circumstances for the release of confidential information.

§ 40.333 - Record retention requirements.

§ 40.345 - Choice of who reports drug testing information to employers.

[65 FR 79526, Dec. 19, 2000. Redesignated at 66 FR 41950, Aug. 9, 2001]

Amendment history

7 distinct wordings on file since Oct. 1, 1996
  1. [65 FR 79526, Dec. 19, 2000. Redesignated at 66 FR 41950, Aug. 9, 2001, as amended at 82 FR 52244, Nov. 13, 2017]
  2. [65 FR 79526, Dec. 19, 2000. Redesignated at 66 FR 41950, Aug. 9, 2001, as amended at 82 FR 52244, Nov. 13, 2017]
  3. [65 FR 79526, Dec. 19, 2000. Redesignated at 66 FR 41950, Aug. 9, 2001]
  4. [65 FR 79526, Dec. 19, 2000. Redesignated at 66 FR 41950, Aug. 9, 2001]
  5. [65 FR 79526, Dec. 19, 2000. Redesignated at 66 FR 41950, Aug. 9, 2001.]
  6. [54 FR 49866, Dec. 1, 1989, as amended at 59 FR 7356, Feb. 15, 1994; 59 FR 43001, Aug. 19, 1994; 63 FR 65129, Nov. 25, 1998]
  7. Oct. 1, 1996 → Oct. 1, 1999annual editions 1996–1998
    [54 FR 49866, Dec. 1, 1989, as amended at 59 FR 7356, Feb. 15, 1994; 59 FR 43001, Aug. 19, 1994]

A new entry appears whenever the regulatory words change between government snapshots. Day-precise from the eCFR (2017 onward); before that, one snapshot per annual CFR edition (revised as of October 1). Bracketed citations are the Federal Register history printed with the section.